Von Willebrand Factor--A New Target for TTP Treatment?
- PMID: 26863360
- DOI: 10.1056/NEJMe1515876
Von Willebrand Factor--A New Target for TTP Treatment?
Comment on
-
Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura.N Engl J Med. 2016 Feb 11;374(6):511-22. doi: 10.1056/NEJMoa1505533. N Engl J Med. 2016. PMID: 26863353 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources